Gene · 974
Papers4,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 4,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cerebrospinal fluid as a liquid biopsy for molecular characterization of brain metastasis in patients with non-small cell lung cancer. | Lung Cancer | 2023 | 37423059 | PubTator, text mining | PubMed |
| Epstein-Barr virus-associated B-cell lymphoproliferative disorder meeting the definition of CAEBV B cell disease: a case report. | BMC Infect Dis | 2023 | 37420238 | PubTator, text mining | PubMed |
| Germinal center-dependent and -independent immune responses of tumor-infiltrating B cells in human cancers. | Cell Mol Immunol | 2023 | 37419983 | PubTator, text mining | PubMed |
| Analysis of the genomic landscape of primary central nervous system lymphoma using whole-genome sequencing in Chinese patients. | Front Med | 2023 | 37418076 | PubTator, text mining | PubMed |
| B cell receptor-induced protein dynamics and the emerging role of SUMOylation revealed by proximity proteomics. | J Cell Sci | 2023 | 37417469 | PubTator, text mining | PubMed |
| Classification and characterisation of extracellular vesicles-related tuberculosis subgroups and immune cell profiles. | J Cell Mol Med | 2023 | 37409682 | PubTator, text mining | PubMed |
| Positron emission tomography-adapted therapy in low-risk diffuse large B-cell lymphoma: results of a randomized, phase III, non-inferiority trial. | Cancer Commun (Lond) | 2023 | 37403255 | PubTator, text mining | PubMed |
| Dissecting the effect of ileal faecal diversion on the intestine using single-cell sequencing. | Clin Transl Med | 2023 | 37400975 | PubTator, text mining | PubMed |
| Recent advances in treatment of nodal and gastrointestinal follicular lymphoma. | World J Gastroenterol | 2023 | 37398889 | PubTator, text mining | PubMed |
| BCR-ABL1-positive acute lymphoblastic leukemia following successful treatment of acute promyelocytic leukemia: case report. | Front Pharmacol | 2023 | 37397496 | PubTator, text mining | PubMed |
| How to Treat Diffuse Large B-Cell Lymphoma: Oncologic and Cardiovascular Considerations. | JACC CardioOncol | 2023 | 37397077 | PubTator, text mining | PubMed |
| ViCloD, an interactive web tool for visualizing B cell repertoires and analyzing intraclonal diversities: application to human B-cell tumors. | NAR Genom Bioinform | 2023 | 37388820 | PubTator, text mining | PubMed |
PTPRC promoted CD8+ T cell mediated tumor immunity and drug sensitivity in breast cancer: based on pan-cancer analysis and artificial intelligence modeling of immunogenic cell death-based drug sensitivity stratification. | Front Immunol | 2023 | 37388747 | PubTator, text mining | PubMed |
| Dyslipidemia in diffuse large B-cell lymphoma based on the genetic subtypes: a single-center study of 259 Chinese patients. | Front Oncol | 2023 | 37384286 | PubTator, text mining | PubMed |
| Mosunetuzumab and lymphoma: latest updates from 2022 ASH annual meeting. | J Hematol Oncol | 2023 | 37381053 | PubTator, text mining | PubMed |
| Precursory or early lesions of follicular lymphoma: clinical features, pathology, and genetics. | J Clin Exp Hematop | 2023 | 37380471 | PubTator, text mining | PubMed |
Single-cell and spatial transcriptomics reveal 5-methylcytosine RNA methylation regulators immunologically reprograms tumor microenvironment characterizations, immunotherapy response and precision treatment of clear cell renal cell carcinoma. | Transl Oncol | 2023 | 37379773 | PubTator, text mining | PubMed |
| Treatment Refractoriness in Chronic Lymphocytic Leukemia: Old and New Molecular Biomarkers. | Int J Mol Sci | 2023 | 37373521 | PubTator, text mining | PubMed |
| Diffuse Large B-Cell Lymphoma in the HIV Setting. | Cancers (Basel) | 2023 | 37370801 | PubTator, text mining | PubMed |
| IL-7 receptor signaling drives human B-cell progenitor differentiation and expansion. | Blood | 2023 | 37369082 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/974/papers?page=30